Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
In addition, over-expression of miR-544 significantly attenuated inflammatory cells infiltration and IL-1, IL-6, TNF- and iNOS production in DN.
|
31323309 |
2020 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
SAC treatment showed significantly decreased levels of blood glucose, glycated haemoglobin, creatinine, albumin, AST, ALT, creatinine kinase, lactate dehydrogenase, and expressions of NF-κB, IL-6, and TNF-α compared with DN control rats.
|
30062492 |
2019 |
Diabetic Nephropathy
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Effect of anemonin was estimated by determining the blood glucose, markers of nephropathy, and mediators of inflammation in the serum and activity of tumor necrosis factor-α (TNF-α)converting enzyme (TACE) in the kidney tissue of DN rats.
|
31344701 |
2019 |
Diabetic Nephropathy
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats.
|
31527864 |
2019 |
Diabetic Nephropathy
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Compared to the NO-CKD group, the NA-DKD group was older with lower hemoglobin (HB) levels and higher systolic blood pressure (SBP), plasma TNF-<i>α</i>, IL-6, and 8-OHdG levels.
|
31637265 |
2019 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
(a) Expression of TREM-1, p-STAT-1, and M1 markers (iNOS and TNF-α) were increased and positively correlated in kidneys from patients with DN.
|
30478987 |
2019 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
The inflammatory response has an important role in the pathophysiology of diabetic nephropathy that is contributed to by inflammatory mediators such as interleukin-1 (IL-1), IL-6, IL-18, tumor necrosis factor-α, and macrophage chemotactic protein-1; however, the role of IL-18 seems to be more specific than other cytokines in the inflammatory process.
|
30417374 |
2019 |
Diabetic Nephropathy
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Diabetic DKD patients showed higher IL-6, IL-10, IFN-γ and TNF-α levels than those without DKD.
|
30015512 |
2019 |
Diabetic Nephropathy
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, we found NF-κB activation and TNF-α excretion were upregulated by Tim-3 in diabetic kidneys, and podocyte injury was associated with the Tim-3-mediated activation of the NF-κB/TNF-α signaling pathway in DN macrophages both in vivo and in vitro.
|
30862474 |
2019 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
This study concludes that serum fetuin-A and pro-inflammatory markers (IL-18, IL-6, IL-1α and TNF-α) might play an important role in the pathophysiology and inflammatory process of DKD.
|
30632070 |
2019 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
Urinary Tf, IgG, NGAL, TNF-α, and the combination of all four biomarkers demonstrated excellent diagnostic value for early-stage DN in patients with type 2 diabetes.
|
31218128 |
2019 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
Circulating TNF receptors 1 and 2 predict progression of diabetic kidney disease: A meta-analysis.
|
31207020 |
2019 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
Together, these data suggest that inflammation, particularly that mediated by the TNF-<i>α</i>/NF-<i>κ</i>B signaling axis, may play a role in the pathogenesis of DKD in African American men.
|
30868076 |
2019 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
In subjects with stage-III DN, liraglutide had favorable effects on renal function (UACR: MD=-11.23, 95% CI=-13.14 to -9.32, P<0.00001; UAER: MD=-14.06; 95% CI=-6.93 to -11.18; P<0.00001; Scr: MD=-9.17, 95% CI=-14.61 to -3.72, P=0.0010) and exhibited anti-inflammatory effects (transforming growth factor-β1: P<0.00001; tumor necrosis factor-α: P=0.006; interleukin-6: P<0.00001).
|
31258671 |
2019 |
Diabetic Nephropathy
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Tumour necrosis factor-related apoptosis-inducing ligand expression in patients with diabetic nephropathy.
|
29999450 |
2019 |
Diabetic Nephropathy
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
The results showed that EA could improve the daily state and body weight; decrease the blood glucose, levels of TNF-α and serum creatinine; elevate the activities of antioxidant enzymes; ameliorate the renal pathology; inhibit the up regulation of expression of proteins TLR4, IRAK4, TRAF6, IKK-β, NF-κBp65 and HMGB1 in DN mice.
|
30342113 |
2019 |
Diabetic Nephropathy
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
The present study was designed to investigate the association of TNF-α [-308G/A, (rs1800629)] single nucleotide polymorphism (SNP) on the susceptibility to DN subjects and to correlate it with the plasma levels of TNF-α along with circulatory TNF-α receptor super family cytokines (sTNFR-1 and sTNFR-2).
|
29042282 |
2018 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
Effector molecules of the innate immune system including C-reactive protein, interleukin-6, and tumor necrosis factor-α are increased in patients with diabetic kidney disease.
|
29910771 |
2018 |
Diabetic Nephropathy
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
The presence of DN involved a lower leukocyte rolling velocity and an increased rolling flux and adhesion. miR-31 levels were positively correlated with leukocyte rolling velocity and negatively associated to leukocyte adhesion, TNFα, IL-6 and ICAM-1 levels.
|
30355913 |
2018 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
Comparison of this murine gene signature with that of human diabetic kidney disease identified shared renal proinflammatory/profibrotic signals (TNF-<i>α</i>, IL-1<i>β</i>, NF-<i>κ</i>B).
|
29490938 |
2018 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
Serum DHA significantly correlated positively with superoxide dismutase and negatively with fractalkine and tumor necrosis factor-α in the patients with DN.
|
29507271 |
2018 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
Inflammatory cytokines such as interleukin 1 (IL-1), IL-6, IL-18 and tumor necrosis factor-α (TNFα) have been linked to the development and progression of DN.
|
29514038 |
2018 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
miR-21 expression was upregulated in serum and kidney tissues of DN patients, kidney tissues of STZ-induced DN rats, and HG-treated podocytes. miR-21 depletion inhibited pro-inflammatory factor (IL-1β, TNF-α) secretions and alleviated kidney damages in STZ-induced DN rats.
|
30212710 |
2018 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
We assessed the association and discrimination obtained with baseline levels of plasma TNF receptor-1 (TNFR-1), TNFR-2, and kidney injury molecule-1 (KIM-1) for the outcomes of incident DKD (ACCORD) and progressive DKD (VA-NEPHRON-D).
|
28476763 |
2017 |
Diabetic Nephropathy
|
0.300 |
Biomarker
|
disease |
BEFREE |
The activation of TLRs stimulates the expression of several inflammatory cytokines and chemokines such as CCL2 and tumor necrosis factor (TNF)-α, which are associated with the progression of diabetic nephropathy.
|
28933050 |
2017 |